Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations

This publication has 56 references indexed in Scilit:

• Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers
  Cancer, 2011
• A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells
  Oncogene, 2010
• Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
  JAMA, 2010
• Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial
  The Lancet, 2009
• How basal are triple‐negative breast cancers?
  International Journal of Cancer, 2008
• Triple negative tumours: a critical review
  Histopathology, 2007
• Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and review
  Breast Cancer Research and Treatment, 2006
• Hallmarks of 'BRCAness' in sporadic cancers
  Nature Reviews Cancer, 2004
• Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer
  JNCI Journal of the National Cancer Institute, 2003
• Repeated observation of breast tumor subtypes in independent gene expression data sets
  Proceedings of the National Academy of Sciences, 2003